Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review

P Nizet, A Evin, E Brociero, CV Vigneau, JF Huon - BMC geriatrics, 2023 - Springer
Background Deprescribing, defined as discontinuing or reducing the dose of medications
that are no longer needed or for which the risks outweigh the benefits is a way to reduce …

Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing

CJ Kelley, JD Niznik, SP Ferreri, C Schlusser… - Drugs & Aging, 2023 - Springer
Abstract Background Opioids and benzodiazepines (BZDs) pose a public health problem.
Older adults are especially susceptible to adverse events from opioids and BZDs owing to …

Patient experiences and clinical outcomes in a multidisciplinary perioperative transitional pain service

D Manoharan, A Xie, YJ Hsu, HK Flynn… - Journal of Personalized …, 2023 - mdpi.com
Siloed pain management across the perioperative period increases the risk of chronic opioid
use and impedes postoperative recovery. Transitional perioperative pain services (TPSs) …

Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain

E Ruggiero, A Pambuku, M Caccese… - Frontiers in Pain …, 2023 - frontiersin.org
Pain is one of the predominant and troublesome symptoms that burden cancer patients
during their whole disease trajectory: adequate pain management is a fundamental …

Determinants of successful opioid deprescribing: Insights from French pain physicians—A qualitative study

P Nizet, L Deme, A Evin, E Kuhn, J Nizard… - Pain …, 2024 - Wiley Online Library
Background Long‐term use of opioids does not result in significant clinical improvement and
has shown more adverse than beneficial effects in chronic pain conditions. When opioids …

Designing a primary care pharmacist-led review for people treated with opioids for persistent pain: a multi-method qualitative study

C Woodcock, N Cornwall, L Dikomitis, SA Harrisson… - BJGP open, 2024 - bjgpopen.org
Background Opioids are frequently prescribed for persistent non-cancer pain despite limited
evidence of long-term effectiveness and risk of harm. Evidence-based interventions to …

Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain

TS Anderson, BX Wang, JH Lindenberg… - JAMA Network …, 2024 - jamanetwork.com
Importance Guidelines recommend deprescribing opioids in older adults due to risk of
adverse effects, yet little is known about patient-clinician opioid deprescribing conversations …

Clinical utility of a mHealth assisted intervention for activity modulation in chronic pain: the pilot implementation of pain ROADMAP

NE Andrews, D Ireland, M Deen… - European Journal of …, 2023 - Wiley Online Library
Background Being able to successfully self‐regulate one's activity levels is a key adaptation
strategy for many people with chronic pain. This study aimed to explore the clinical utility of a …

Patients' perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients

JM Fischer, FI Kandil, E Katsarova, LS Zager… - Frontiers in …, 2023 - frontiersin.org
Introduction Since cannabinoids were partially legalized as prescription medicines in
Germany in 2017, they are mostly used when conventional therapies do not suffice …

Realities of opioid and gabapentinoid deprescribing in socioeconomically disadvantaged communities: qualitative evaluation

CL Parbery-Clark, JS Portice, S Sowden - BJGP open, 2024 - bjgpopen.org
Background Opioid and gabapentinoid prescribing has increased substantially in recent
years despite having limited effectiveness in treating chronic primary pain. This is …